|
1
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang XY and Zhang PY: Gastric cancer:
Somatic genetics as a guide to therapy. J Med Genet. 54:305–312.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Japanese Gastric Cancer Association, .
Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric
Cancer. 20:1–19. 2017. View Article : Google Scholar
|
|
5
|
Sano T: Gastric cancer: Asia and the
world. Gastric Cancer. 20 (Suppl 1):S1–S2. 2017. View Article : Google Scholar
|
|
6
|
Rahman R, Asombang AW and Ibdah JA:
Characteristics of gastric cancer in Asia. World J Gastroenterol.
20:4483–4490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goldenring JR: The AGA/Funderburg award in
gastric cancer: Twenty-five years of advances in gastric cancer
research. Gastroenterology. 152:1262–1266. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bekaii-Saab T and El-Rayes B: Identifying
and targeting cancer stem cells in the treatment of gastric cancer.
Cancer. 123:1303–1312. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song S, Tan J, Miao Y and Zhang Q:
Crosstalk of ER stress-mediated autophagy and ER-phagy: Involvement
of UPR and the core autophagy machinery. J Cell Physiol.
233:3867–3874. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sarvani C, Sireesh D and Ramkumar KM:
Unraveling the role of ER stress inhibitors in the context of
metabolic diseases. Pharmacol Res. 119:412–421. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coppola-Segovia V, Cavarsan C, Maia FG,
Ferraz AC, Nakao LS, Lima MM and Zanata SM: ER stress induced by
tunicamycin triggers alpha-Synuclein oligomerization, dopaminergic
neurons death and locomotor impairment: A New model of Parkinson's
disease. Mol Neurobiol. 54:5798–5806. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rahmati M, Moosavi MA and McDermott MF: ER
stress: A therapeutic target in rheumatoid arthritis? Trends
Pharmacol Sci. 39:610–623. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hetz C: The unfolded protein response:
Controlling cell fate decisions under ER stress and beyond. Nat Rev
Mol Cell Biol. 13:89–102. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Smith M and Wilkinson S: ER homeostasis
and autophagy. Essays Biochem. 61:625–635. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koga T, Suico MA, Shimasaki S, Watanabe E,
Kai Y, Koyama K, Omachi K, Morino-Koga S, Sato T, Shuto T, et al:
Endoplasmic reticulum (ER) stress induces Sirtuin 1 (SIRT1)
expression via the PI3K-Akt-GSK3β signaling pathway and promotes
hepatocellular injury. J Biol Chem. 290:30366–30374. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mohamed E, Cao Y and Rodriguez PC:
Endoplasmic reticulum stress regulates tumor growth and anti-tumor
immunity: A promising opportunity for cancer immunotherapy. Cancer
Immunol Immunother. 66:1069–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Papaioannou A and Chevet E: Driving Cancer
tumorigenesis and metastasis through UPR signaling. Curr Top
Microbiol Immunol. 414:159–192. 2018.PubMed/NCBI
|
|
18
|
Kim C and Kim B: Anti-cancer natural
products and their bioactive compounds inducing ER stress-mediated
apoptosis: A review. Nutrients. 10(pii): E10212018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang B, Han H, Fu S, Yang P, Gu Z, Zhou Q
and Cao Z: Dehydroeffusol inhibits gastric cancer cell growth and
tumorigenicity by selectively inducing tumor-suppressive
endoplasmic reticulum stress and a moderate apoptosis. Biochem
Pharmacol. 104:8–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen W, Zou P, Zhao Z, Chen X, Fan X,
Vinothkumar R, Cui R, Wu F, Zhang Q, Liang G and Ji J: Synergistic
antitumor activity of rapamycin and EF24 via increasing ROS for the
treatment of gastric cancer. Redox Biol. 10:78–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Panciera T, Azzolin L, Cordenonsi M and
Piccolo S: Mechanobiology of YAP and TAZ in physiology and disease.
Nat Rev Mol Cell Biol. 18:758–770. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Andl T, Zhou L, Yang K, Kadekaro AL and
Zhang Y: YAP and WWTR1: New targets for skin cancer treatment.
Cancer Lett. 396:30–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zanconato F, Cordenonsi M and Piccolo S:
YAP/TAZ at the roots of cancer. Cancer Cell. 29:783–803. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sorrentino G, Ruggeri N, Zannini A,
Ingallina E, Bertolio R, Marotta C, Neri C, Cappuzzello E, Forcato
M, Rosato A, et al: Glucocorticoid receptor signalling activates
YAP in breast cancer. Nat Commun. 8:140732017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia Y, Chang T, Wang Y, Liu Y, Li W, Li M
and Fan HY: YAP promotes ovarian cancer cell tumorigenesis and is
indicative of a poor prognosis for ovarian cancer patients. PLoS
One. 9:e917702014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hall CA, Wang R, Miao J, Oliva E, Shen X,
Wheeler T, Hilsenbeck SG, Orsulic S and Goode S: Hippo pathway
effector Yap is an ovarian cancer oncogene. Cancer Res.
70:8517–8525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brown JS, O'Carrigan B, Jackson SP and Yap
TA: Targeting DNA repair in cancer: Beyond PARP inhibitors. Cancer
Discov. 7:20–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan Z, Tian Y, Zhang B, Zhang X, Shi H,
Liang Z, Wu P, Li R, You B, Yang L, et al: YAP signaling in gastric
cancer-derived mesenchymal stem cells is critical for its promoting
role in cancer progression. Int J Oncol. 51:1055–1066. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma L, Cui J, Xi H, Bian S, Wei B and Chen
L: Fat4 suppression induces Yap translocation accounting for the
promoted proliferation and migration of gastric cancer cells.
Cancer Biol Ther. 17:36–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu P, Xue J, Zhang ZJ, Jia YP, Tong YN,
Han D, Li Q, Xiang Y, Mao XH and Tang B: Helicobacter pylori VacA
induces autophagic cell death in gastric epithelial cells via the
endoplasmic reticulum stress pathway. Cell Death Dis. 8:32072017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yokozaki H: Molecular characteristics of
eight gastric cancer cell lines established in Japan. Pathol Int.
50:767–777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang XR, Wang SY, Sun W and Wei C:
Isoliquiritigenin inhibits proliferation and metastasis of MKN28
gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling
pathway. Mol Med Rep. 18:3429–3436. 2018.PubMed/NCBI
|
|
33
|
Noto A, De Vitis C, Pisanu ME, Roscilli G,
Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati
O, Trisciuoglio D, et al: Stearoyl-CoA-desaturase 1 regulates lung
cancer stemness via stabilization and nuclear localization of
YAP/TAZ. Oncogene. 36:4573–4584. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu P, Hu S, Jin Q, Li D, Tian F, Toan S,
Li Y, Zhou H and Chen Y: Ripk3 promotes ER stress-induced
necroptosis in cardiac IR injury: A mechanism involving calcium
overload/XO/ROS/mPTP pathway. Redox Biol. 16:157–168. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li R, Yang HQ, Xi HL, Feng S and Qin RH:
Inhibition of CDH17 gene expression via RNA interference reduces
proliferation and apoptosis of human MKN28 gastric cancer cells.
Int J Oncol. 50:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ye H, Wang WG, Cao J and Hu XC: SPARCL1
suppresses cell migration and invasion in renal cell carcinoma. Mol
Med Rep. 16:7784–7790. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu SH, Lee WJ, Lai DW, Wu SM, Liu CY,
Tien HR, Chiu CS, Peng YC, Jan YJ, Chao TH, et al: Honokiol confers
immunogenicity by dictating calreticulin exposure, activating ER
stress and inhibiting epithelial-to-mesenchymal transition. Mol
Oncol. 9:834–849. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yan Y, Liu S, Li M, Zhao Y, Shao X, Hang M
and Bu X: Recombinant Newcastle disease virus expressing human
IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to
endoplasmic reticulum stress pathways. Thorac Cancer. 9:1437–1452.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kennedy D, Mnich K, Oommen D, Chakravarthy
R, Almeida-Souza L, Krols M, Saveljeva S, Doyle K, Gupta S,
Timmerman V, et al: HSPB1 facilitates ERK-mediated phosphorylation
and degradation of BIM to attenuate endoplasmic reticulum
stress-induced apoptosis. Cell Death Dis. 8:e30262017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Yuan J, Zhang X, Yan F, Huang M,
Wang T, Zheng X and Zhang M: Angiomotin promotes the malignant
potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT
signaling pathway. Oncol Rep. 36:3619–3626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yan H, Qiu C, Sun W, Gu M, Xiao F, Zou J
and Zhang L: Yap regulates gastric cancer survival and migration
via SIRT1/Mfn2/mitophagy. Oncol Rep. 39:1671–1681. 2018.PubMed/NCBI
|
|
43
|
Jiao S, Wang H, Shi Z, Dong A, Zhang W,
Song X, He F, Wang Y, Zhang Z, Wang W, et al: A peptide mimicking
VGLL4 function acts as a YAP antagonist therapy against gastric
cancer. Cancer Cell. 25:166–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qiao Y, Chen J, Lim YB, Finch-Edmondson
ML, Seshachalam VP, Qin L, Jiang T, Low BC, Singh H, Lim CT and
Sudol M: YAP regulates actin dynamics through ARHGAP29 and promotes
metastasis. Cell Rep. 19:1495–1502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cubillos-Ruiz JR, Bettigole SE and
Glimcher LH: Tumorigenic and immunosuppressive effects of
endoplasmic reticulum stress in cancer. Cell. 168:692–706. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dumartin L, Alrawashdeh W, Trabulo SM,
Radon TP, Steiger K, Feakins RM, di Magliano MP, Heeschen C,
Esposito I, Lemoine NR and Crnogorac-Jurcevic T: ER stress protein
AGR2 precedes and is involved in the regulation of pancreatic
cancer initiation. Oncogene. 36:3094–3103. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen PP, Ma XY, Lin Q, Xu HL, Shi HX,
Zhang HY, Xiao J, Geng FN and Zhao YZ: Kangfuxin promotes apoptosis
of gastric cancer cells through activating ERstress and autophagy.
Mol Med Rep. 16:9043–9050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim JL, Lee DH, Na YJ, Kim BR, Jeong YA,
Lee SI, Kang S, Joung SY, Lee SY, Oh SC and Min BW: Iron
chelator-induced apoptosis via the ER stress pathway in gastric
cancer cells. Tumour Biol. 37:9709–9719. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hersey P and Zhang XD: Adaptation to ER
stress as a driver of malignancy and resistance to therapy in human
melanoma. Pigment Cell Melanoma Res. 21:358–367. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ye J and Koumenis C: ATF4, an ER stress
and hypoxia-inducible transcription factor and its potential role
in hypoxia tolerance and tumorigenesis. Curr Mol Med. 9:411–416.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Feng R, Zhai WL, Yang HY, Jin H and Zhang
QX: Induction of ER stress protects gastric cancer cells against
apoptosis induced by cisplatin and doxorubicin through activation
of p38 MAPK. Biochem Biophys Res Commun. 406:299–304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hou S, Wang L and Zhang G: Mitofusin-2
regulates inflammation-mediated mouse neuroblastoma N2a cells
dysfunction and endoplasmic reticulum stress via the Yap-Hippo
pathway. J Physiol Sci. 69:697–709. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ashokkumar R, Jamuna S, Sakeena Sadullah
MS and Niranjali Devaraj S: Vitexin protects isoproterenol induced
post myocardial injury by modulating hipposignaling and ER stress
responses. Biochem Biophys Res Commun. 496:731–737. 2018.
View Article : Google Scholar : PubMed/NCBI
|
